Your browser doesn't support javascript.
loading
Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma.
Wu, Xiaohui; Tang, Haijia; Xu, Wen-Hao; Tang, Haidan; Wei, Shiyin; Anwaier, Aihetaimujiang; Huang, Haineng; Qu, Yuan-Yuan; Zhang, Hailiang; Zhao, Shuai; Li, Hui; Liu, Wangrui; Chen, Hongjing; Ding, Chen; Ye, Dingwei.
Afiliação
  • Wu X; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China.
  • Tang H; Department of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Xu WH; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China.
  • Tang H; Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
  • Wei S; Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
  • Anwaier A; Department of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Huang H; Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
  • Qu YY; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China.
  • Zhang H; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China.
  • Zhao S; Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li H; Department of Endocrinology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Liu W; Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
  • Chen H; Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ding C; Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, China.
  • Ye D; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China.
Front Genet ; 12: 751977, 2021.
Article em En | MEDLINE | ID: mdl-34950188
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça